Skip to main content
. 2019 Apr 30;9:316. doi: 10.3389/fonc.2019.00316

Table 3.

Pediatric T-cell acute lymphoblastic leukemia and overall survival in univariate analysis, 2005-2017, Brazil.

Variables pOS % (SE) Mean* (SE) 95%CI p-value
AGE (YEARS)
<1 22.2 (0.19) 22.0 (9.58) (3.2–40.8) 0.036
1–10 66.7 (0.52) 45.3 (2.23) (40.9–49.7)
≥ 10 58.3 (0.57) 40.9 (2.62) (35.9–46.1)
LYMPH NODE INFILTRATION
Yes 68.8 (0.44) 45.9 (1.95) (42.1–49.8) 0.008
No 49.2 (0.69) 36.8 (3.20) (30.6–43.1)
MEDIASTINAL MASS
Yes 70.8 (0.56) 47.5 (2.37) (42.8–52.1) 0.044
No 56.7 (0.50) 40.1 (2.33) (35.5–44.7)
T-ALL SUBTYPES
Immature vs 78.5 (0.09) 49.8 (4.10) (41.8–57.8) 0.109
Others 59.5 (0.04) 41.9 (1.84) (38.3–45.5)
Mature SP vs 49.4 (0.13) 36.8 (5.73) (25.6–48.1) 0.194
Others 63.5 (0.04) 43.6 (1.77) (40.2–47.1)
MOLECULAR ALTERATIONS
NOTCH1mut/FBXW7mut 67.6 (0.55) 46.3 (2.33) (41.8–50.9) 0.027
NOTCH1WT/FBXW7WT 55.3 (0.62) 37.8 (3.08) (31.8–43.8)
STIL/TAL1pos 47.6 (0.90) 33.6 (4.51) (24.8–42.5) 0.006
STIL/TAL1neg 66.0 (0.47) 45.4 (2.00) (41.5–49.3)
MYB amp 46.7 (0.17) 31.5 (8.84) (14.2–48.8) 0.113
MYBWT 64.4 (0.51) 43.7 (2.30) (39.2–48.2)
Total 62.0 (0.04) 42.8 (1.70) (39.5–46.1)

pOS, probability of overall survival; SE, standard error, CI, confidence interval; SP, CD4 and/or CD8 simple positive; mut, mutated; WT, wild type; pos, positive; neg, negative; amp, amplified.

*

mean survival in months.